2015
DOI: 10.1053/j.gastro.2014.10.041
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus

Abstract: Background & AimsBarrett's esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC). We found the risk to be BE has been associated with single nucleotide polymorphisms (SNPs) on chromosome 6p21 (within the HLA region) and on 16q23, where the closest protein-coding gene is FOXF1. Subsequently, the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) identified risk loci for BE and esophageal adenocarcinoma near CRTC1 and BARX1, and within 100 kb of FOXP1. We aimed to identify further SNPs th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
94
1

Year Published

2015
2015
2018
2018

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 91 publications
(99 citation statements)
references
References 49 publications
4
94
1
Order By: Relevance
“…BARX1 is an important repressor of the Wnt signaling pathway during development (discussed above). In addition, TBX5, a transcription factor that was identified in the largest GWAS to date (62), is a key regulator of limb development through the regulation of the expression of Wnt ligands (83). The third GWAS also identified a locus near GDF7, a member of the BMP pathway that is interesting in the light of the potential role of BMP signaling in the development of Barrett's esophagus discussed below.…”
Section: Esophageal Epithelial Pathophysiology the Development Of Bamentioning
confidence: 99%
See 1 more Smart Citation
“…BARX1 is an important repressor of the Wnt signaling pathway during development (discussed above). In addition, TBX5, a transcription factor that was identified in the largest GWAS to date (62), is a key regulator of limb development through the regulation of the expression of Wnt ligands (83). The third GWAS also identified a locus near GDF7, a member of the BMP pathway that is interesting in the light of the potential role of BMP signaling in the development of Barrett's esophagus discussed below.…”
Section: Esophageal Epithelial Pathophysiology the Development Of Bamentioning
confidence: 99%
“…Genomewide association studies (GWAS) that examined genetic predisposition to the development of Barrett's esophagus have implicated several pathways with a role in the development of the esophagus (38,62,81). One of the most significant associations with the development of Barrett's esophagus found in the first large GWAS is a single-nucleotide polymorphism (SNP) that is very close to FOXF1 (81), the mesenchymally expressed Hedgehog target that acts upstream of BMP4 during development (see above).…”
Section: Esophageal Epithelial Pathophysiology the Development Of Bamentioning
confidence: 99%
“…20 Recent large-scale genomewide association studies () have provided comprehensive assessments of genetic susceptibility to BE and OA. [21][22][23][24][25] Novel associations have been identified with variants in or near several transcription factors implicated in embryonic oesophageal development, a transcriptional coactivator and the human leucocyte antigen (HLA) region. It remains likely, however, that additional loci that did not satisfy the commonly used, stringent statistical threshold ( p<5×10 −8 ) may be involved in modifying disease risk.…”
Section: Significance Of This Studymentioning
confidence: 99%
“…Recent large-scale GWAS have provided comprehensive assessments of inherited genetic susceptibility to BE and EA [24, 25, 26, 27, 28]. Novel associations have been identified with variants in or near several transcription factors implicated in embryonic esophageal development, a transcriptional co-activator, and the human leukocyte antigen (HLA) region.…”
Section: Introductionmentioning
confidence: 99%
“…To validate these findings, Palles et al [5] performed a GWAS to identify variants associated with BE and further analyzed promising variants identified by BEACON by genotyping 10,158 patients with BE and 21,062 controls. As a result, 2 SNPs not previously associated with BE were reported: rs3072 (2p24.1; OR = odds ratio = 1.14; 95% CI: 1.09-1.18; p = 1.8 × 10− 11 ) and rs2701108 (12q24.21; OR = 0.90; 95% CI: 0.86-0.93; p = 7.5 × 10− 9 ).…”
Section: Esophageal Adenocarcinomamentioning
confidence: 99%